Market Access, Novartis
Scott Howell is Vice President, Market Access (MA) for US Pharmaceuticals at
Novartis Pharmaceuticals Corporation, a position he has held since June 2017.
Scott leads all areas of MA including Pricing and Contracting, Managed Care,
Distribution, and Patient Services. He also serves as a member of the
US Pharmaceuticals Executive Committee (PEC).
Prior to joining Novartis, Scott served as Vice President of Market Access at Jazz
Pharmaceuticals, a rare disease and orphan drug company, where he led a fully
integrated pricing, contracting, distribution, reimbursement and managed care
department. Previously, he worked for Cardinal Health as Senior Vice President,
Clinical Services and spent a number of years at Genentech where he held a
variety of leadership positions in the Market Access environment. Earlier in his
career, Scott was Vice President, Pharmacy Affairs at Highmark Blue Cross Blue
Shield where he led the pharmacy program. Before Highmark, he held a variety of
managed care leadership roles at SmithKline Beecham/GlaxoSmithKline.
Scott began his career as a general internist and worked several years in private
practice before working in academic medicine at the Ohio State University. He
has been lecturing on health policy and industry strategy for a number of years,
primarily in the graduate programs at U.C. Berkeley, and has co-authored and
contributed to a number of industry-related papers.
Scott earned his undergraduate degree at Notre Dame and his medical degree at
Ohio State. He completed his medical internship and residency and also earned an
M.B.A at Duke University.